Vioguard Inc., a Bothell, WA-based provider of ultraviolet disinfection solutions, raised $5m in Series A financing.
Imagen Capital Partners made the investment. With this investment, Imagen Capital Partners will designate two persons to join the Vioguard board of directors.
The company, which has raised $11m in total funding to date, intends to use the funds to expand its sales and marketing efforts, as well as, broaden and accelerate product development initiatives.
Established in 2008 and led by Laurance Ranta, President and Chief Executive Officer, Vioguard provides UV-C technology solutions designed to enhance the effectiveness of infection control strategies.
Its patented flagship product is a self-sanitizing automated keyboard and mouse system that uses germicidal ultraviolet light, known as UV-C, cleared by the U.S. Food and Drug Administration, which kills all bacteria, viruses, fungi, and drug-resistant pathogens that have been proven to be responsible for millions of Hospital-Acquired Infections (HAIs) worldwide.
The company currently holds multiple patents in the UV space for sanitizing surfaces, such as computer keyboards, touchscreens, telephones, escalator handrails, writing implements, as well as various other surfaces and input devices.
Additional product introductions are expected to include an escalator handrail sanitizer and a pen sterilizing device, both projected to be released across 2017.